Correlation Between Dianthus Therapeutics and Avid Bioservices

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Avid Bioservices at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Avid Bioservices into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Avid Bioservices, you can compare the effects of market volatilities on Dianthus Therapeutics and Avid Bioservices and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Avid Bioservices. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Avid Bioservices.

Diversification Opportunities for Dianthus Therapeutics and Avid Bioservices

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Dianthus and Avid is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Avid Bioservices in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avid Bioservices and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Avid Bioservices. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avid Bioservices has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Avid Bioservices go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and Avid Bioservices

Given the investment horizon of 90 days Dianthus Therapeutics is expected to under-perform the Avid Bioservices. In addition to that, Dianthus Therapeutics is 6.62 times more volatile than Avid Bioservices. It trades about -0.09 of its total potential returns per unit of risk. Avid Bioservices is currently generating about 0.0 per unit of volatility. If you would invest  1,225  in Avid Bioservices on September 12, 2024 and sell it today you would lose (0.50) from holding Avid Bioservices or give up 0.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dianthus Therapeutics  vs.  Avid Bioservices

 Performance 
       Timeline  
Dianthus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dianthus Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
Avid Bioservices 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Avid Bioservices are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak primary indicators, Avid Bioservices may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Dianthus Therapeutics and Avid Bioservices Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dianthus Therapeutics and Avid Bioservices

The main advantage of trading using opposite Dianthus Therapeutics and Avid Bioservices positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Avid Bioservices can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will offset losses from the drop in Avid Bioservices' long position.
The idea behind Dianthus Therapeutics and Avid Bioservices pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities